VHL and renal cell carcinoma: The identification that mutations to both VHL and nearby genes on chromosome 3p can act as the first events causing tumorigenesis in several forms of RCC (both hereditary and sporadic) has opened the door to treatment approaches in a patient-specific fashion (see below).